Recursion Pharmaceuticals (RXRX) has drawn attention after recent trading, with the share price closing at US$3.42 and short term returns showing pressure over the past week, month and past 3 months.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the AI stocks that will go to the moon. On February 18, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) came under pressure after regulatory ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Today is Microsoft's March 2026 Patch Tuesday with security updates for 79 flaws, including 2 publicly disclosed zero-day ...

A fully autonomous AI agent has claimed the top of HackerOne’s bug bounty leaderboard – and this month it submitted a CVSS 9.8 remote code execution flaw to Microsoft via HackerOne that the company ...

Magic: The Gathering’s Teenage Mutant Ninja Turtles crossover set is almost here, celebrating more than 40 years of turtle history across movies, cartoons, comics, and games with 190 new cards in the ...